Robert D. Ciappenelli - Dec 13, 2021 Form 4 Insider Report for Dicerna Pharmaceuticals Inc (DRNA)

Role
Chief Strategy Officer
Signature
/s/ Douglas W. Pagan, attorney-in-fact
Stock symbol
DRNA
Transactions as of
Dec 13, 2021
Transactions value $
$199,968
Form type
4
Date filed
12/14/2021, 08:02 PM
Previous filing
Jun 15, 2021
Next filing
Dec 17, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DRNA Common Stock Options Exercise $200K +8.86K +234.72% $22.58 12.6K Dec 13, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DRNA Employee Stock Option (Right to Buy) Options Exercise $0 -8.86K -10.42% $0.00 76.1K Dec 13, 2021 Common Stock 8.86K $22.58 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in 48 substantially equal monthly installments, with the first installment vesting on the last day of January 2020, and the remaining shares vesting on the last day of each of the 47 months thereafter; subject in each case to the reporting person's continued service with the issuer through each applicable vesting date.